Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

GM Helix Acqua Implant,Ti,3.75X13: medical device reports filed with FDA

2,259 reports name it, 2020–2026. Manufacturer given most often on reports: Jjgc. Product code DZE.

2,259
device reports naming the brand
0% of all MAUDE reports · about 348 a year
836
reports, 12 months to August 2026
592 in the 12 months before
0%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 2,259 reports that name the brand "GM Helix Acqua Implant,Ti,3.75X13" (endosseous dental implant), received between January 2020 and August 2026; the manufacturer given most often on reports is Jjgc. Spellings of one product vary from report to report.

836 reports arrived in the 12 months to August 2026, up 41% from 592 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (100%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (82.1%), loss of osseointegration (11.9%) and difficult to insert (0.9%). The patient problems coded most often are pain, fibrosis and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

071142Sep 2021: 8Oct 2021: 8Nov 2021: 11Dec 2021: 32022Jan 2022: 7Feb 2022: 8Mar 2022: 16Apr 2022: 9May 2022: 16Jun 2022: 16Jul 2022: 16Aug 2022: 21Sep 2022: 20Oct 2022: 21Nov 2022: 12Dec 2022: 192023Jan 2023: 10Feb 2023: 9Mar 2023: 29Apr 2023: 19May 2023: 46Jun 2023: 33Jul 2023: 17Aug 2023: 15Sep 2023: 21Oct 2023: 29Nov 2023: 21Dec 2023: 242024Jan 2024: 23Feb 2024: 31Mar 2024: 31Apr 2024: 41May 2024: 26Jun 2024: 31Jul 2024: 50Aug 2024: 30Sep 2024: 49Oct 2024: 36Nov 2024: 43Dec 2024: 382025Jan 2025: 37Feb 2025: 55Mar 2025: 54Apr 2025: 25May 2025: 0Jun 2025: 142Jul 2025: 60Aug 2025: 53Sep 2025: 47Oct 2025: 60Nov 2025: 57Dec 2025: 642026Jan 2026: 52Feb 2026: 64Mar 2026: 100Apr 2026: 46May 2026: 83Jun 2026: 108Jul 2026: 83Aug 2026: 72

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

03276542020: 3020202021: 8420212022: 18120222023: 27320232024: 42920242025: 65420252026: 6082026

Event type and report source

Event type, as classified on the report

Death0%0
Injury100%2,259
Malfunction0%0
Other0%0
Not given0%0

Who filed the report

Manufacturer report92.4%2,088
Voluntary report0%0
User facility report0%0
Distributor report7.6%171
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate1,85482.1%62.8%
Loss of osseointegration26911.9%22.4%
Difficult to insertthe device was hard to insert210.9%0.4%
Fracturea broken bone50.2%1.6%
Separation failure30.1%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Painpain, site not specified55524.6%
Fibrosis49722%
Inflammationinflammation1245.5%
Hemorrhage/blood loss/bleeding1104.9%
Swelling/ edema1084.8%
Fistula743.3%
Abscessa collection of pus542.4%
Hyperresponsive to stimuli301.3%
Hypersensitivity/allergic reaction150.7%
Tissue damage140.6%
Sinus perforation130.6%
Numbnessnumbness80.4%
Swellingswelling40.2%
Failure of implant10%
Inadequate osseointegration10%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureGM Helix Acqua Implant,Ti,3.75X13Product code DZEAll MAUDE reports
Reports2,2593,924,24126,136,888
Share of that pool—0.1%0%
Classified as death, per 1,000 reports009
Classified as injury100%99.2%36.2%
Classified as malfunction0%0.8%62.3%
Filed by the manufacturer92.4%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about GM Helix Acqua Implant,Ti,3.75X13 reports

How many FDA reports name GM Helix Acqua Implant,Ti,3.75X13?

2,259 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 836 in the latest 12 months.

What kinds of events are reported?

injury (100%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (82.1%), loss of osseointegration (11.9%), difficult to insert (0.9%), fracture (0.2%) and separation failure (0.1%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (92.4%) and distributor reports (7.6%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that GM Helix Acqua Implant,Ti,3.75X13 was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.